Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01597141 · ClinicalTrials.gov registry record · NA

Psychosis: Early Detection, Intervention and Prevention

A NA study of Psychotic Disorders and Prodromal Schizophrenia, sponsored by MaineHealth.

Completed
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT01597141 is a NA study of Psychotic Disorders and Prodromal Schizophrenia that has completed, run by MaineHealth. The registered enrollment target is 100 participants, below the 251-participant average among 22 other Psychotic Disorders trials with a reported enrollment target (60% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01597141, a NA study of Psychotic Disorders and Prodromal Schizophrenia, has completed, sponsored by MaineHealth.

COMPLETED
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

The primary aim of this application is to conduct a randomized, controlled clinical trial of a specialized mental health service delivery system specifically developed for prodromal psychotic disorders. The intervention is Family-aided Assertive Community Treatment (FACT). The goal of the treatment is prevention of psychosis and disability. This study will assess experimentally the clinical effectiveness of this new type of mental health service. Other domains of outcome include cognitive dysfunction and functional disability.

Interventions

  • BEHAVIORAL Family-aided Assertive Community Treatment
  • BEHAVIORAL Enhanced standard treatment

Study Locations (1)

Maine

  • Maine Medical Center - Portland

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2003-05
Est. Completion 2014-12
Phase NA

Sponsor

MaineHealth

26 total trials

What the Registry Record Tells You About NCT01597141

The ClinicalTrials.gov registry entry for NCT01597141 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 251-participant average among 22 other Psychotic Disorders trials with a reported enrollment target (60% lower). The listed sponsor is MaineHealth, which has 26 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Psychotic Disorders appearing as the primary indexed condition, and to 2 interventions - of which Family-aided Assertive Community Treatment is the first listed.

NCT01597141 reports 1 study location spanning 1 distinct geographic area - top geographies include Maine.

Frequently Asked Questions

What is clinical trial NCT01597141 about?

NCT01597141 is a clinical study titled "Psychosis: Early Detection, Intervention and Prevention". The primary aim of this application is to conduct a randomized, controlled clinical trial of a specialized mental health service delivery system specifically developed for prodromal psychotic disorders. The intervention is Family-aided Assertive Community Treatment (FACT). The goal of the treatment ...

What is the current status of trial NCT01597141?

This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2003-05. Estimated completion is 2014-12.

What conditions does trial NCT01597141 study?

This clinical trial studies the following conditions: Psychotic Disorders, Prodromal Schizophrenia, Severe Bipolar Disorder With Psychotic Features, Severe Major Depression With Psychotic Features.

What interventions are being tested in trial NCT01597141?

The interventions under investigation include: Family-aided Assertive Community Treatment (BEHAVIORAL), Enhanced standard treatment (BEHAVIORAL).

Who is sponsoring clinical trial NCT01597141?

This trial is sponsored by MaineHealth, which has 26 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01597141 being conducted?

This trial has 1 study location across Maine. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Psychotic Disorders

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.